Ciprofloxacin-resistant Haemophilus influenzae infection in a patient with chronic lung disease

OBJECTIVE: To report a case of ciprofloxacin-resistant Haemophilus influenzae infection in a patient with chronic lung disease who was exposed to multiple courses of antimicrobial therapy. CASE SUMMARY: The patient suffered recurrent pulmonary infections and developed bronchiectasis as a consequence of longstanding, severe, combined immunodeficiency disease. He had received ciprofloxacin on several occasions for treatment and prophylaxis of recurrent pulmonary infections. On a recent admission his usual H. influenzae isolate, which had been highly susceptible to ciprofloxacin (minimum inhibitory concentration [MIC] < or = 0.06 mg/L) on previous admissions, was resistant to ciprofloxacin and ofloxacin (MIC 8 and 16 mg/L, respectively). The patient responded to treatment with ceftizoxime and was discharged with oral cefixime, which was to be taken for a total of two weeks. DISCUSSION: Rare isolates of H. influenzae resistant to ofloxacin and lomefloxacin have been noted in Europe and Asia; however, none resistant to the fluoroquinolones have been previously reported in the US, and no resistance has been reported to ciprofloxacin. We believe that repetitive, cycling exposure to ciprofloxacin may have induced the resistance that developed in this patient's flora. CONCLUSIONS: Fluoroquinolones may be added to the list of drugs to which H. influenzae have become resistant. Only judicious use of these drugs will preserve their activity against important pathogens in community-acquired infections.

This article has been cited by other articles:

				M. Perez-Vazquez, F. Roman, S. Garcia-Cobos, and J. Campos Fluoroquinolone Resistance in Haemophilus influenzae Is Associated with Hypermutability Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1566 - 1569. [Abstract] [Full Text] [PDF]

				K. P. Heilmann, C. L. Rice, A. L. Miller, N. J. Miller, S. E. Beekmann, M. A. Pfaller, S. S. Richter, and G. V. Doern Decreasing Prevalence of {beta}-Lactamase Production among Respiratory Tract Isolates of Haemophilus influenzae in the United States Antimicrob. Agents Chemother., June 1, 2005; 49(6): 2561 - 2564. [Abstract] [Full Text] [PDF]

				X. Li, N. Mariano, J. J. Rahal, C. M. Urban, and K. Drlica Quinolone-Resistant Haemophilus influenzae in a Long-Term-Care Facility: Nucleotide Sequence Characterization of Alterations in the Genes Encoding DNA Gyrase and DNA Topoisomerase IV Antimicrob. Agents Chemother., September 1, 2004; 48(9): 3570 - 3572. [Abstract] [Full Text] [PDF]

				M. Perez-Vazquez, F. Roman, B. Aracil, R. Canton, and J. Campos Laboratory Detection of Haemophilus influenzae with Decreased Susceptibility to Nalidixic Acid, Ciprofloxacin, Levofloxacin, and Moxifloxacin Due to gyrA and parC Mutations J. Clin. Microbiol., March 1, 2004; 42(3): 1185 - 1191. [Abstract] [Full Text] [PDF]

				I. Morrissey and G. Tillotson Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae J. Antimicrob. Chemother., February 1, 2004; 53(2): 144 - 148. [Abstract] [Full Text] [PDF]

				M. Perez-Vazquez, F. Roman, M. C. Varela, R. Canton, and J. Campos Activities of 13 quinolones by three susceptibility testing methods against a collection of Haemophilus influenzae isolates with different levels of susceptibility to ciprofloxacin: evidence for cross-resistance J. Antimicrob. Chemother., January 1, 2003; 51(1): 147 - 151. [Abstract] [Full Text] [PDF]

				J. Vila, J. Ruiz, F. Sanchez, F. Navarro, B. Mirelis, M. T. J. de Anta, and G. Prats Increase in Quinolone Resistance in a Haemophilus influenzae Strain Isolated from a Patient with Recurrent Respiratory Infections Treated with Ofloxacin Antimicrob. Agents Chemother., January 1, 1999; 43(1): 161 - 162. [Abstract] [Full Text]